AEGIS-II

Objective

The purpose of this study is to find out how effective and safe CSL112 (study drug) is at reducing the risk of death from heart related events, having another heart attack or stroke in patients who have experienced a recent myocardial infarction (heart attack).

View this clinical trail on ClinicalTrials.gov.

Location:

Essentia Health Duluth

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 10/16/2018

Research Study Categories

  • Adult Studies

Specialty

  • Cardiology
Contact
Cardiology Clinical Trials at 866-839-4128
or clinicaltrials@essentiahealth.org

Like most websites, we use cookies and other technologies to keep our website reliable, secure, and to better understand how our site is used. By using our site, you agree to our use of these tools. Learn more.